litlas
Log inCreate account

Stephen L. Hauser

Active 1975–2025

Also published as
Stephen L Hauser
213
Papers
47,397
Citations
111
h-index
206
i10-index

Citations

Citations per year for Stephen L. Hauser1973: 2 citations1975: 1 citations1976: 1 citations1977: 2 citations1978: 5 citations1979: 5 citations1980: 6 citations1981: 11 citations1982: 13 citations1983: 19 citations1984: 14 citations1985: 22 citations1986: 19 citations1987: 16 citations1988: 29 citations1989: 18 citations1990: 26 citations1991: 19 citations1992: 13 citations1993: 16 citations1994: 14 citations1995: 28 citations1996: 43 citations1997: 84 citations1998: 104 citations1999: 121 citations2000: 116 citations2001: 159 citations2002: 142 citations2003: 120 citations2004: 130 citations2005: 162 citations2006: 163 citations2007: 144 citations2008: 277 citations2009: 308 citations2010: 418 citations2011: 369 citations2012: 331 citations2013: 335 citations2014: 334 citations2015: 374 citations2016: 327 citations2017: 371 citations2018: 496 citations2019: 1,321 citations2020: 1,503 citations2021: 1,619 citations2022: 1,478 citations2023: 1,122 citations2024: 1,883 citations2025: 1,006 citations2026: 31 citations1974: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,559 citing papers, 25.8% of this breakdownUnited Kingdom: 1,404 citing papers, 7.9% of this breakdownGermany: 1,376 citing papers, 7.8% of this breakdownItaly: 979 citing papers, 5.5% of this breakdownCanada: 868 citing papers, 4.9% of this breakdownChina: 793 citing papers, 4.5% of this breakdownSwitzerland: 651 citing papers, 3.7% of this breakdownFrance: 594 citing papers, 3.4% of this breakdownSpain: 576 citing papers, 3.2% of this breakdownAustralia: 567 citing papers, 3.2% of this breakdownNetherlands: 528 citing papers, 3% of this breakdownSweden: 394 citing papers, 2.2% of this breakdown
0%25.8%Other 24.9%

Institutions

Fields

  • Medicine56.7%
  • Biochemistry, Genetics and Molecular Biology21%
  • Immunology and Microbiology10.1%
  • Neuroscience8.9%
  • Agricultural and Biological Sciences0.6%
  • Computer Science0.4%
  • Other2.3%

Topics

  • Multiple Sclerosis Research Studies13.5%
  • T-cell and B-cell Immunology4.1%
  • Peripheral Neuropathies and Disorders3.8%
  • Neuroinflammation and Neurodegeneration Mechanisms3.5%
  • Immunotherapy and Immune Responses2.6%
  • Immune Cell Function and Interaction2.2%
  • Other70.3%

Coauthors

All papers

Open in search
  1. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

    Authors: Stephen L. Hauser, Amit Bar‐Or, Gıancarlo Comı, Gavin Giovannoni, Hans‐Peter Hartung, Bernhard Hemmer, Fred Lublin, Xavier Montalbán, Kottil Rammohan, Krzysztof Selmaj, Anthony Traboulsee, Jerry S. Wolinsky, Douglas L. Arnold, Gaëlle Klingelschmitt, Donna Masterman, Paulo Fontoura, Shibeshih Belachew, Peter Chin, Nicole Mairon, Hideki Garren, Ludwig Kappos - New England Journal of Medicine 2016 cited by 1,961

  2. Treatment of Multiple Sclerosis: A Review

    Authors: Stephen L. Hauser, Bruce Cree - The American Journal of Medicine 2020 cited by 938

  3. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

    Authors: Ludwig Kappos, Jerry S. Wolinsky, Gavin Giovannoni, Douglas L. Arnold, Qing Wang, Corrado Bernasconi, Fabian Model, Harold Koendgen, Marianna Manfrini, Shibeshih Belachew, Stephen L. Hauser - JAMA Neurology 2020 cited by 622

  4. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Authors: Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar‐Or, Giancarlo Comi, de Sèze, Gavin Giovannoni, Hans‐Peter Hartung, Bernhard Hemmer, Fred Lublin, Kottil Rammohan, Krzysztof Selmaj, Anthony Traboulsee, Annette Sauter, Donna Masterman, Paulo Fontoura, Shibeshih Belachew, Hideki Garren, Nicole Mairon, Peter Chin, Jerry S. Wolinsky - New England Journal of Medicine 2016 cited by 1,856

  5. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models

    Authors: Egle Cekanaviciute, Bryan B. Yoo, Tessel F. Runia, Justine W. Debelius, Sneha Singh, Charlotte Nelson, Rachel Kanner, Yadira Bencosme, Yun Kyung Lee, Stephen L. Hauser, Elizabeth Crabtree‐Hartman, Ilana Katz Sand, Mar Gacias, Yunjiao Zhu, Patrizia Casaccia, Bruce Cree, Rob Knight, Sarkis K. Mazmanian, Sergio E. Baranzini - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 1,050

  6. Ofatumumab versus Teriflunomide in Multiple Sclerosis

    Authors: Stephen L. Hauser, Amit Bar‐Or, Jeffrey Cohen, Gıancarlo Comı, Jorge Correale, Patricia K. Coyle, Anne H. Cross, de Sèze, David Leppert, Xavier Montalbán, Krzysztof Selmaj, Heinz Wiendl, Cécile Kerloëguen, Roman Willi, Bingbing Li, Algirdas Kakarieka, Davorka Tomic, Alexandra Goodyear, Ratnakar Pingili, Dieter A. Häring, Krishnan Ramanathan, Martin Merschhemke, Ludwig Kappos - New England Journal of Medicine 2020 cited by 700

  7. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course

    Authors: Xiaoyuan Zhou, Ryan Baumann, Xiaohui Gao, Myra Mendoza, Sneha Singh, Ilana Katz Sand, Zongqi Xia, Laura M. Cox, Tanuja Chitnis, Hongsup Yoon, Laura Moles, Stacy J. Caillier, Adam Santaniello, Gail Ackermann, Adil Harroud, Robin Lincoln, Refujia Gomez, Antonio González Peña, Elise Digga, Daniel Hakim, Yoshiki Vázquez‐Baeza, Karthik Soman, Shannon Warto, Greg Humphrey, Mauricio Farez, Lisa Ann Gerdes, Jorge R. Oksenberg, Scott S. Zamvil, Siddharthan Chandran, Peter Connick, David Otaegui, Tamara Castillo‐Triviño, Stephen L. Hauser, Jeffrey M. Gelfand, Howard L. Weiner, Reinhard Hohlfeld, Hartmut Wekerle, Jennifer Graves, Amit Bar‐Or, Bruce Cree, Jorge Correale, Rob Knight, Sergio E. Baranzini - Cell 2022 cited by 319

  8. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

    Authors: Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold, Timothy R. Vollmer, Jack P. Antel, Robert J. Fox, Amit Bar‐Or, Michael Panzara, Neena Sarkar, Sunil Agarwal, Annette Langer‐Gould, Craig H. Smith - New England Journal of Medicine 2008 cited by 2,399

  9. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

    Authors: Ari Green, Jeffrey M. Gelfand, Bruce Cree, Carolyn Bevan, W. John Boscardin, Feng Mei, Justin Inman, Sam Arnow, Michael Devereux, Aya Abounasr, Hiroko Nobuta, Alyssa H. Zhu, Matt Friessen, Roy Gerona, H.‐Christian von Büdingen, Roland G. Henry, Stephen L. Hauser, Jonah R. Chan - The Lancet 2017 cited by 577

  10. Silent progression in disease activity–free relapsing multiple sclerosis

    Authors: Bruce Cree, Jill A. Hollenbach, Riley Bove, Gina Kirkish, Simone Sacco, Eduardo Caverzasi, Antje Bischof, Tristan Gundel, Alyssa H. Zhu, Nico Papinutto, W. Stern, Carolyn Bevan, Andrew R. Romeo, Douglas S. Goodin, Jeffrey M. Gelfand, Jennifer Graves, Ari Green, Michael R. Wilson, Scott S. Zamvil, Chao Zhao, Refujia Gomez, Nicholas R. Ragan, Gillian Rush, Patrick Barba, Adam Santaniello, Sergio E. Baranzini, Jorge R. Oksenberg, Roland G. Henry, Stephen L. Hauser - Annals of Neurology 2019 cited by 455

  11. Role of B Cells in Multiple Sclerosis and Related Disorders

    Authors: Gıancarlo Comı, Amit Bar‐Or, Hans Lassmann, Antonio Uccelli, Hans‐Peter Hartung, Xavier Montalbán, Per Solberg Sørensen, Reinhard Hohlfeld, Stephen L. Hauser - Annals of Neurology 2020 cited by 278

  12. KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19

    Authors: Jing Li, Maxim Zaslavsky, Yapeng Su, Jing Guo, Michael J. Sikora, Vincent van Unen, Asbjørn Christophersen, Shin‐Heng Chiou, Liang Chen, Jun Li, Xuhuai Ji, Julie Wilhelmy, Alana M. McSween, Brad A. Palanski, Vamsee Mallajosyula, Nathan A. Bracey, Gopal Krishna Dhondalay, Kartik Bhamidipati, Joy A. Pai, Lucas Kipp, Jeffrey Dunn, Stephen L. Hauser, Jorge R. Oksenberg, Ansuman T. Satpathy, William H. Robinson, Cornelia L. Dekker, Lars M. Steinmetz, Chaitan Khosla, Paul J. Utz, Ludvig M. Sollid, Yueh‐hsiu Chien, James R. Heath, Nielsen Fernandez‐Becker, Kari C. Nadeau, Naresha Saligrama, Mark M. Davis - Science 2022 cited by 245

  13. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis

    Authors: Feng Mei, Stephen P.J. Fancy, Yun‐An Shen, Jianqin Niu, Chao Zhao, Bryan Presley, Edna Miao, Seonok Lee, Sonia R. Mayoral, Stephanie Redmond, Ainhoa Etxeberría, Lan Xiao, Robin J.M. Franklin, Ari Green, Stephen L. Hauser, Jonah R. Chan - Nature Medicine 2014 cited by 590

  14. Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

    Authors: Walter J. Curran, Rebecca Paulus, Corey J. Langer, R. Komaki, Jong Seok Lee, Stephen L. Hauser, B. Movsas, Todd H. Wasserman, Seth A. Rosenthal, Elizabeth Gore, Mitchell Machtay, William T. Sause, James D. Cox - JNCI Journal of the National Cancer Institute 2011 cited by 1,235

  15. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

    Authors: Colm Elliott, Jerry S. Wolinsky, Stephen L. Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew, Douglas L. Arnold - Multiple Sclerosis Journal 2018 cited by 214

  16. Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial

    Authors: Kathleen Hawker, Paul O’Connor, Mark S. Freedman, Peter A. Calabresi, Jack P. Antel, Jack H. Simon, Stephen L. Hauser, Emmanuelle Waubant, Timothy Vollmer, Hillel Panitch, Jiameng Zhang, Peter Chin, Craig H. Smith, OLYMPUS trial group - Annals of Neurology 2009 cited by 939

  17. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis

    Authors: Colm Elliott, Shibeshih Belachew, Jerry S. Wolinsky, Stephen L. Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Julian Fecker, Fabian Model, Wei Wei, Douglas L. Arnold - Brain 2019 cited by 215

  18. Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials

    Authors: Amit Bar‐Or, Gian‐Andrea Thanei, Christopher Harp, Corrado Bernasconi, Ulrike Bonati, Anne H. Cross, Saloumeh K Fischer, Laura Gaetano, Stephen L. Hauser, Robert L. Hendricks, Ludwig Kappos, Jens Kühle, David Leppert, Fabian Model, Annette Sauter, Harold Koendgen, Xiaoming Jia, Ann Herman - EBioMedicine 2023 cited by 88

  19. Gut microbiota–specific IgA + B cells traffic to the CNS in active multiple sclerosis

    Authors: Anne‐Katrin Pröbstel, Xiaoyuan Zhou, Ryan Baumann, Sven Wischnewski, Michael Kutza, Olga L. Rojas, Katrin Sellrie, Antje Bischof, Kicheol Kim, Akshaya Ramesh, Ravi Dandekar, Ariele L. Greenfield, Ryan Schubert, Jordan E. Bisanz, Stephanie Vistnes, Khashayar Khaleghi, James Landefeld, Gina Kirkish, Friederike Liesche‐Starnecker, Valeria Ramaglia, Sneha Singh, Edwina B. Tran, Patrick Barba, Kelsey C. Zorn, Johanna Oechtering, Karin Forsberg, Lawrence R. Shiow, Roland G. Henry, Jennifer Graves, Bruce Cree, Stephen L. Hauser, Jens Kühle, Jeffrey M. Gelfand, Peter M. Andersen, Jürgen Schlegel, Peter J. Turnbaugh, Peter H. Seeberger, Jennifer L. Gommerman, Michael R. Wilson, Lucas Schirmer, Sergio E. Baranzini - Science Immunology 2020 cited by 219

  20. Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis

    Authors: Stephen L. Hauser, Ludwig Kappos, Xavier Montalbán, Licínio Craveiro, Cathy Chognot, Richard A. Hughes, Harold Koendgen, Noemi Pasquarelli, Ashish Pradhan, Kalpesh Prajapati, Jerry S. Wolinsky - Neurology 2021 cited by 177

  21. Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis

    Authors: Ahmed Abdelhak, Pascal Benkert, Sabine Schaedelin, W. John Boscardin, Christian Cordano, Johanna Oechtering, Kirtana Ananth, Cristina Granziera, Lester Melie‐García, Shivany Condor Montes, Alexandra Beaudry‐Richard, Lutz Achtnichts, Frederike Cosima Oertel, Patrice H. Lalive, David Leppert, Stefanie Müller, Roland G. Henry, Caroline Pot, Amandine Matthias, Anke Salmen, Jorge R. Oksenberg, Giulio Disanto, Chiara Zecca, Marcus D’Souza, Renaud Du Pasquier, Claire Bridel, Claudio Gobbi, Ludwig Kappos, Stephen L. Hauser, Bruce Cree, Jens Kühle, Ari Green, UCSF, MS EPIC, and the SMSC Study Teams, Sergio E. Baranzini, Riley Bove, Michael R. Wilson, Jill A. Hollenbach, Refujia Gomez, Adam Santaniello, Meagan Harms, Tiffany Cooper, Stacy J. Caillier, Johannes Lorscheider, Alessandro Cagol, Muhamed Baraković, Riccardo Galbusera, Özgür Yaldizli, Suvitha Subramaniam, Annette Orleth, Tobias Derfuß, Aleksandra Maleska Maceski, Eline A.J. Willemse, Lars G. Hemkens, Perrine Janiaud, Lilian Demuth, Bettina Fischer‐Barnicol, Robert Hoepner, Andrew Chan, Oliver Findling - JAMA Neurology 2023 cited by 91

  22. Five years of ocrelizumab in relapsing multiple sclerosis

    Authors: Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar‐Or, Bruno Brochet, Robert T. Naismith, Anthony Traboulsee, Jerry S. Wolinsky, Shibeshih Belachew, Harold Koendgen, Victoria Levesque, Marianna Manfrini, Fabian Model, Stanislas Hubeaux, Lahar Mehta, Xavier Montalbán - Neurology 2020 cited by 158

  23. CAR-T Cell–Mediated B-Cell Depletion in Central Nervous System Autoimmunity

    Authors: Sasha Gupta, Milos Simic, Sharon A. Sagan, Chanelle Shepherd, Jason Duecker, Raymond A. Sobel, Ravi Dandekar, Gregory F. Wu, Wesley Wu, John E. Pak, Stephen L. Hauser, Wendell A. Lim, Michael R. Wilson, Scott S. Zamvil - Neurology Neuroimmunology & Neuroinflammation 2023 cited by 66

  24. Long‐term evolution of multiple sclerosis disability in the treatment era

    Authors: Bruce Cree, Pierre‐Antoine Gourraud, Jorge R. Oksenberg, Carolyn Bevan, Elizabeth Crabtree‐Hartman, Jeffrey M. Gelfand, Douglas S. Goodin, Jennifer Graves, Ari Green, Ellen M. Mowry, Darin T. Okuda, Daniel Pelletier, H.‐Christian von Büdingen, Scott S. Zamvil, Alisha Agrawal, Stacy J. Caillier, Caroline Ciocca, Refujia Gomez, Rachel Kanner, Robin Lincoln, Antoine Lizée, Pamela Qualley, Adam Santaniello, Leena Suleiman, Monica Bucci, Valentina Panara, Nico Papinutto, W. Stern, Alyssa H. Zhu, Gary Cutter, Sergio E. Baranzini, Roland G. Henry, Stephen L. Hauser - Annals of Neurology 2016 cited by 436